Helminths (including anthelmintic resistance) roadmap:
Vaccines
Roadmap for nematode vaccine development
Download Nematode Vaccine Roadmap
---
config:
theme: default
defaultRenderer: 'elk'
themeVariables:
lineColor: "red"
---
flowchart LR
34990["
5
DNA/RNA vaccines- ASafety
- BDelivery route
- CDelivery platform
- DEfficacy in challenge model
1
Vaccine6
Subunit vaccine- ASafety
- BDelivery route
- CDelivery platform
- DEfficacy in challenge model
1
Vaccine7
Vectored vaccines- ASafety
- BDelivery route
- CDelivery platform
- DEfficacy in challenge model
1
Vaccine9
Adjuvant5
DNA/RNA vaccines- ASafety
- BDelivery route
- CDelivery platform
- DEfficacy in challenge model
9
Adjuvant6
Subunit vaccine- ASafety
- BDelivery route
- CDelivery platform
- DEfficacy in challenge model
10
Expression system9
Adjuvant11
Vector7
Vectored vaccines- ASafety
- BDelivery route
- CDelivery platform
- DEfficacy in challenge model
12
Identity of protective antigens10
Expression system12
Identity of protective antigens9
Adjuvant12
Identity of protective antigens11
Vector13
Identity of virulence factors12
Identity of protective antigens14
Identity of immunomodulators12
Identity of protective antigens15
Host responses to natural infection12
Identity of protective antigens15
Host responses to natural infection16
Identity of mechanisms of protection- AAntibody response
- BCell-mediated immunity
16
Identity of mechanisms of protection- AAntibody response
- BCell-mediated immunity
12
Identity of protective antigens17
Host-pathogen interactions- AEntry
- BReplication
- CPersistence/ clearance
15
Host responses to natural infection17
Host-pathogen interactions- AEntry
- BReplication
- CPersistence/ clearance
14
Identity of immunomodulators17
Host-pathogen interactions- AEntry
- BReplication
- CPersistence/ clearance
13
Identity of virulence factors17
Host-pathogen interactions- AEntry
- BReplication
- CPersistence/ clearance
18
Challenge model19
Pathogen genome17
Host-pathogen interactions- AEntry
- BReplication
- CPersistence/ clearance
| Lead Summary | Challenges and gap analysis | |
|---|---|---|
| 1 | Vaccine | Polyvalent vaccine giving long-lasting protection against infection by the predominant nematode species infecting livestock |
| 5D | Efficacy in challenge model | |
| 5C | Delivery platform | |
| 5B | Delivery route | |
| 5A | Safety | |
| 5 | DNA/RNA vaccines | Development of nucleic acid-based vaccines |
| 6D | Efficacy in challenge model | |
| 6C | Delivery platform | |
| 6B | Delivery route | |
| 6A | Safety | |
| 6 | Subunit vaccine | Development of a native anti-parasite vaccine |
| 7D | Efficacy in challenge model | |
| 7C | Delivery platform | |
| 7B | Delivery route | |
| 7A | Safety | |
| 7 | Vectored vaccines | Development of a vectored vaccine |
| 9 | Adjuvant | Conventional and molecular adjuvants |
| 10 | Expression system | Expression system for subunit vaccine |
| 11 | Vector | Vector identification for vectored vaccine |
| 12 | Identity of protective antigens | Identity of protective antigens |
| 13 | Identity of virulence factors | Identity of parasite virulence factors |
| 14 | Identity of immunomodulators | Identity of immunomodulators |
| 15 | Host responses to natural infection | Host response to natural infection |
| 16B | Cell-mediated immunity | |
| 16A | Antibody response | |
| 16 | Identity of mechanisms of protection | Identity of mechanisms of protection |
| 17C | Persistence/ clearance | |
| 17B | Replication | |
| 17A | Entry | |
| 17 | Host-pathogen interactions | Host-parasite interactions |
| 18 | Challenge model | Challenge model |
| 19 | Pathogen genome | Pathogen genome |